切换至 "中华医学电子期刊资源库"

中华肾病研究电子杂志 ›› 2015, Vol. 04 ›› Issue (02) : 60 -63. doi: 10.3877/cma.j.issn.2095-3216.2015.02.001

所属专题: 文献

述评

关注贫困人群的慢性肾脏病
谢院生1,(), 魏凯1, 陈香美1   
  1. 1. 100853 北京,解放军总医院肾脏病科、解放军肾脏病研究所、肾脏疾病国家重点实验室、国家慢性肾病临床医学研究中心
  • 出版日期:2015-04-28
  • 通信作者: 谢院生
  • 基金资助:
    国家重大科学研究计划项目(2011CB944004)

Paying more attention to chronic kidney disease in disadvantaged populations

Yuansheng Xie1,(), Kai Wei1, Xiangmei Chen1   

  1. 1. Department of Nephrology, Chinese People′s Liberation Army General Hospital, Chinese People′s Liberation Army Institute of Nephrology, State Key Laboratory of Kidney Diseases, National Clinical Research Center for Kidney Diseases, Beijing 100853, China
  • Published:2015-04-28
  • Corresponding author: Yuansheng Xie
  • About author:
    Corresponding author: Xie Yuansheng, Email:
引用本文:

谢院生, 魏凯, 陈香美. 关注贫困人群的慢性肾脏病[J/OL]. 中华肾病研究电子杂志, 2015, 04(02): 60-63.

Yuansheng Xie, Kai Wei, Xiangmei Chen. Paying more attention to chronic kidney disease in disadvantaged populations[J/OL]. Chinese Journal of Kidney Disease Investigation(Electronic Edition), 2015, 04(02): 60-63.

慢性肾脏病(CKD),由于其患病率高、预后差、医疗费用高,已成为全球性公共卫生问题。贫困人群由于经济状况、生活方式、生活环境和就医条件等方面的原因,肾脏疾病的发生率更高,肾脏替代疗法的应用率更低,预后更差,经济负担更重。因此,应给予贫困人群CKD更多的关注。2015年第十个世界肾脏日的主题是关注贫困人群的CKD,号召全民关注肾脏健康。本文重点阐述贫穷与CKD之间的关系,旨在提高贫困人群CKD的防治水平。

Chronic kidney disease (CKD) has become a global public health problem due to its high prevalence, poor prognosis, and high cost. Due to the poor economic conditions, lifestyles, living environment, medical conditions, and other aspects, disadvantaged populations have a higher incidence of kidney disease, lower application rates of renal replacement therapy, worse prognosis, and heavier economic burden. Therefore, more attention should be given to CKD in disadvantaged populations. The theme of the tenth World Kidney Day 2015 is to pay attention to the CKD in disadvantaged populations, and appeal to everyone to take good care of their kidneys. This paper focuses on the relationship between poverty and CKD, and aims to improve the prevention and treatment for CKD in disadvantaged populations.

[1]
Collins AJ, Couser WG, Dirks JH, et al. World Kidney Day: an idea whose time has come [J]. J Am Soc Nephrol, 2006,17(3): 600-601.
[2]
Levey AS, Andreoli SP, DuBose T, et al. Chronic kidney disease: common, harmful, and treatable-World Kidney Day 2007 [J]. J Am Soc Nephrol, 2007, 18(2): 374-378.
[3]
Garcia-Garcia G, Jha V. World Kidney Day 2015: CKD in disadvantaged populations [J]. Am J Kidney Dis, 2015, 65(3): 394-353.
[4]
Crews DC, Charles RF, Evans MK, et al. Poverty, race, and CKD in a racially and socioeconomically diverse urban population [J]. Am J Kidney Dis, 2010, 55(6): 992-1000.
[5]
Sachs JD. Macroeconomics and health: investing in health for economic development [J]. Rev Panam Salud Publica, 2002, 12(2): 143-144.
[6]
Kalantar-Zadeh K, Block G, Humphreys MH, et al. Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients [J]. Kidney Int, 2003, 63(3): 793-808.
[7]
Hsu C-y, Lin F, Vittinghoff E, et al. Racial differences in the progression from chronic renal insufficiency to end-stage renal disease in the United States [J]. J Am Soc Nephrol, 2003, 14(11): 2902-2907.
[8]
Norris K, Nissenson AR. Race, gender, and socioeconomic disparities in CKD in the United States [J]. J Am Soc Nephrol, 2008, 19(7): 1261-1270.
[9]
Bruce MA, Beech BM, Crook ED, et al. Association of socioeconomic status and CKD among African Americans: the Jackson Heart Study [J]. Am J Kidney Dis, 2010, 55(6): 1001-1008.
[10]
Volkova N, McClellan W, Klein M, et al. Neighborhood poverty and racial differences in ESRD incidence [J]. J Am Soc Nephrol, 2008, 19(2): 356-364.
[11]
Sabanayagam C, Lim SC, Wong TY, et al. Ethnic disparities in prevalence and impact of risk factors of chronic kidney disease [J]. Nephrol Dial Transplant, 2010, 25(8): 2564-2570.
[12]
McDonald S. Incidence and treatment of ESRD among indigenous peoples of Australasia[J]. Clin Nephrol, 2010, 74(Suppl 1): S28-S31.
[13]
Collins J. Kidney disease in Maori and Pacific people in New Zealand [J]. Clin Nephrol, 2010, 74 (Suppl 1): S61-S65.
[14]
Weil EJ, Nelson RG. Kidney disease among the indigenous peoples of Oceania [J]. Ethn Dis, 2005, 16(2 Suppl 2): 24-30.
[15]
Jha V, Garcia-Garcia G, Iseki K, et al. Chronic kidney disease: global dimension and perspectives [J]. Lancet, 2013, 382(9888): 260-272.
[16]
Almaguer M, Herrera R, Orantes CM. Chronic kidney disease of unknown etiology in agricultural communities [J]. MEDICC Rev, 2014, 16(2): 9-15.
[17]
Obrador GT, García-García G, Villa AR, et al. Prevalence of chronic kidney disease in the Kidney Early Evaluation Program (KEEP) Mexico and comparison with KEEP US [J]. Kidney Int Suppl, 2010, 77(116): S2-S8.
[18]
Gutierrez-Padilla JA, Mendoza-Garcia M, Plascencia-Perez S, et al. Screening for CKD and cardiovascular disease risk factors using mobile clinics in Jalisco, Mexico [J]. Am J Kidney Dis, 2010, 55(3): 474-484.
[19]
García-García G, Gutiérrez-Padilla AJ, Chávez-Iñiguez J, et al. Identifying undetected cases of chronic kidney disease in Mexico. Targeting high-risk populations [J]. Arch Med Res, 2013, 44(8): 623-627.
[20]
Amato D, Alvarez-Aguilar C, Castañeda-Limones R, et al. Prevalence of chronic kidney disease in an urban Mexican population [J]. Kidney Int, 2005, 68(97): S11-S17.
[21]
Ulasi II, Ijoma CK, Onodugo OD, et al. Towards prevention of chronic kidney disease in Nigeria: a community-based study in Southeast Nigeria [J]. Kidney Int Suppl, 2013, 3(2): 195-201.
[22]
Otieno LS, McLigeyo SO, Luta M. Acute renal failure following the use of herbal remedies [J]. East Afr Med J, 1991, 68(12): 993-998.
[23]
Zhang L, Wang F, Wang L, et al. Prevalence of chronic kidney disease in China: a cross-sectional survey [J]. Lancet, 2012, 379(9818): 815-822.
[24]
Xu Y, Wang L, He J, et al. Prevalence and control of diabetes in Chinese adults[J]. JAMA, 2013, 310(9): 948-959.
[25]
谢院生. 药物所致急性肾衰的防治经验[J]. 中国综合临床,1990, 6(2): 91-93.
[26]
Hoy W, McDonald SP. Albuminuria: marker or target in indigenous populations [J]. Kidney Int Suppl, 2004, 66(92): S25-S31.
[27]
McDonald SP, Maguire GP, Hoy WE. Renal function and cardiovascular risk markers in a remote Australian aboriginal community [J]. Nephrol Dial Transplant, 2003, 18(8): 1555-1561.
[28]
Lackland DT, Bendall HE, Osmond C, et al. Low birth weights contribute to the high rates of early-onset chronic renal failure in the southeastern United States [J]. Arch Int Med, 2000, 160(10): 1472-1476.
[29]
Bhargava SK, Sachdev HS, Fall CH, et al. Relation of serial changes in childhood body-mass index to impaired glucose tolerance in young adulthood [J]. N Engl J Med, 2004, 350(9): 865-875.
[30]
Hoy WE, Samuel T, Mott SA, et al. Renal biopsy findings among Indigenous Australians: a nationwide review [J]. Kidney Int, 2012, 82(12): 1321-1331.
[31]
Hoy W, Hughson M, Zimanyi M, et al. Distribution of volumes of individual glomeruli in kidneys at autopsy: association with age, nephron number, birth weight and body mass index [J]. Clin Nephrol, 2010, 74(Suppl 1): S105-S112.
[32]
Liyanage T, Ninomiya T, Jha V, et al. Worldwide access to treatment for end stage kidney disease: a systematic review [J]. Lancet, 2015, Epub ahead of print.
[33]
Barsoum RS. Chronic kidney disease in the developing world [J]. N Engl J Med, 2006, 354(10): 997-999.
[34]
Jha V. Current status of end-stage renal disease care in India and Pakistan [J]. Kidney Int Suppl, 2013, 3(2): 157-160.
[35]
Garcia-Garcia G, Monteon-Ramos JF, Garcia-Bejarano H, et al. Renal replacement therapy among disadvantaged populations in Mexico: a report from the Jalisco Dialysis and Transplant Registry (REDTJAL) [J]. Kidney Int Suppl, 2005, 68(97): S58-S61.
[36]
Caskey FJ. Renal replacement therapy: can we separate the effects of social deprivation and ethnicity [J]? Kidney Int Suppl, 2013, 3(2): 246-249.
[37]
Yeates KE, Cass A, Sequist TD, et al. Indigenous people in Australia, Canada, New Zealand and the United States are less likely to receive renal transplantation [J]. Kidney Int, 2009, 76(6): 659-664.
[38]
Garcia GG, Harden P, Chapman J, et al. The global role of kidney transplantation [J]. Lancet, 2012, 379(9820): e36-e38.
[39]
Nakai S, Iseki K, Itami N, et al. An overview of regular dialysis treatment in Japan (as of 31 December 2010) [J]. Ther Apher Dial, 2012, 16(6): 483-521.
[40]
Jha V. Current status of chronic kidney disease care in southeast Asia [J]. Semin Nephrol, 2009, 29(5): 487-496.
[1] 凌淑洵, 涂玥, 刘思逸. 间充质干细胞在慢性肾脏病研究领域现状和趋势的知识图谱可视化分析[J/OL]. 中华细胞与干细胞杂志(电子版), 2024, 14(02): 73-82.
[2] 中华医学会器官移植学分会, 中国医师协会器官移植医师分会. 中国肝移植受者肾损伤管理临床实践指南(2023版)[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(03): 276-288.
[3] 程柏凯, 杨光. 高胰岛素-正葡萄糖钳夹技术评估慢性肾脏病患者胰岛素抵抗的研究进展[J/OL]. 中华肾病研究电子杂志, 2024, 13(06): 334-339.
[4] 郭俊楠, 林惠, 任艺林, 乔晞. 氨基酸代谢异常在急性肾损伤向慢性肾脏病转变中的作用研究进展[J/OL]. 中华肾病研究电子杂志, 2024, 13(05): 283-287.
[5] 冯熔熔, 苏晓乐, 王利华. 慢性肾脏病患者并发心血管疾病相关生物标志物研究进展[J/OL]. 中华肾病研究电子杂志, 2024, 13(05): 273-278.
[6] 王小龙, 吴杰, 段姝伟, 王超卉, 潘娜, 白圆圆, 李航天, 蔡广研. 不同等级体力活动对慢性肾脏病患者预后的影响[J/OL]. 中华肾病研究电子杂志, 2024, 13(03): 121-128.
[7] 肖伍豪, 刘抗寒. 晚期慢性肾脏病患者骨质疏松症的治疗研究进展[J/OL]. 中华肾病研究电子杂志, 2024, 13(02): 92-96.
[8] 吴燕升, 张先闻, 王琳. 慢性肾脏病患者肠道微生态与免疫的关系研究进展[J/OL]. 中华肾病研究电子杂志, 2024, 13(02): 101-105.
[9] 张轶男, 朱国贞. 急性肾损伤向慢性肾脏病转变研究进展[J/OL]. 中华肾病研究电子杂志, 2024, 13(02): 106-112.
[10] 洪权. 肾脏疾病中的代谢重编程:新机制与新的治疗机会[J/OL]. 中华肾病研究电子杂志, 2024, 13(01): 60-60.
[11] 奚培培, 周加军. 慢性肾脏病患者肌少症机制和诊治的研究进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(05): 491-495.
[12] 韦美菊, 潘玲. 肠道菌群-胆汁酸代谢轴在慢性肾脏病中的研究进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(02): 219-222.
[13] 袁蔡骏, 闻萍, 徐玲玲. 连续血糖监测在慢性肾脏病合并糖尿病患者中的应用研究进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(01): 79-82.
[14] 易成, 韦伟, 赵宇亮. 急性肾脏病的概念沿革[J/OL]. 中华临床医师杂志(电子版), 2023, 17(08): 906-910.
[15] 罗婷, 邱令智, 易东, 鄢华. 线粒体功能障碍与心血管疾病、缺血性脑卒中及慢性肾脏病关系的研究进展[J/OL]. 中华脑血管病杂志(电子版), 2024, 18(01): 60-63.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?